Monday, July 2, 2007
Britain Needs A Sherpa!
Posted by
Steve Murphy MD
at
7:45 AM
5
comments
Labels: coumadin, direct to consumer, DNA direct, Eye on DNA, gene sherpa, gene tests, genetic counselor, london, UK
Saturday, June 30, 2007
WBUR posts on coumadin and Personalized Medicine!

Despite the heavy Boston accent,
On WBUR Carol's worries regarding Coumadin and Personalized Medicine hit home to millions of patients everywhere. This is an excellent example of the press' coverage of my specialty. Dr Sam Goldhaber a physician at Mass General talks about the promise of pharmacogenomic testing in blood thinning and avoidance of its horrible side effects.
Lastly they interview the Pope of Personalized Medicine
Francis says "Is this the scenario we want personalized medicine to enter?"
"The public thinks that this is snake oil (i.e. Direct to consumer testing and nutrigenomics)"
The Sherpa Says: "Save Betty!!!" We must take the time to educate everyone about the promise and pitfalls of personalized medicine. In My Humble Opinion, the only thing to move physcians will be the slew of lawsuits that happen after we publicize our great outcomes at Helix Health of Connecticut.
Posted by
Steve Murphy MD
at
4:43 PM
2
comments
Labels: coumadin, DNA direct, francis collins, gene doping, gene tests, Harvard, personalized medicine, scienceroll
Thursday, June 28, 2007
This Week in NEJM
Table 2. Reveals risk of SSRI use in relation to birth defects.
This week in The New England Journal of Medicine 2 articles comment on a once thought problem during pregnancy. Women taking anti-depressants called Selective Serotonin Reuptake Inhibitors (SSRIs) were warned about these drugs which were considered a danger to development of the child. From one study:
Conclusions: Our findings do not show that there are significantly increased risks of craniosynostosis, omphalocele, or heart defects associated with SSRI use overall. They suggest that individual SSRIs may confer increased risks for some specific defects, but it should be recognized that the specific defects implicated are rare and the absolute risks are small......Our analysis did not confirm previously reported associations between overall use of SSRIs and craniosynostosis, omphalocele, or heart defects as a group
The problem is that drugs are not routinely tested on pregnant women. This results in an unknown effect on the fetus/child prior to giving the medicine. The only answers we have are on women who had taken a drug prior to knowing they were pregnant. This leads to very few drugs being available for use in pregnancy.
In addition to the birth defect risk there is a problem with Serotonin Withdrawal Syndrome in the child. While I was a resident in pediatrics at my prior institution I saw 2 patients in 1 month with this horrible problem. It was a tough thing to see those little babies writhing from the withdrawal. They eventually adapted to the lack of serotonin, but I wonder how well the mother would have done with the pregnancy if she was depressed.
The Sherpa Says: Is this personalized medicine? Not Really. But it does have to do with genetics and development. Besides the risk for birth defects, there is another risk for the child. Too bad it is only glossed over in these articles :(
Posted by
Steve Murphy MD
at
2:00 PM
0
comments
Labels: birth defects, craniosynostosis, heart defects, omphalocele, pregnancy, serotonin, SSRI
Tuesday, June 26, 2007
The Confusing Thing About Association Studies.
- Long Term Aspirin use prevents cancer incidence in colon 32%, prostate 19%, and breast cancer 17%* (statistically non-significant). There is some molecular evidence of this in colon cancer. But not the others....... The catch is that you have to use aspirin adult dose for >5 years. Why? Like most association studies.....No one knows. What good is that?
- Hormone replacement therapy increases Ovarian cancer incidence This study called the Million Women Study is a large cohort of British women. 948,576 postmenopausal women were assessed for ovarian cancer incidence. Users were 20% more likely to develop Ovarian Cancer. 1 in 5, that seems small, but in a million women (well......just 52k shy) that's alot of cancer!!! Especially such a nasty killer. But here's the kicker....
- Oral Contraceptive hormones Reduce Colorectal Cancer risk! Wait a second.....Aren't these female hormones too? This study shows an almost 40% reduced incidence of colon cancer in these women from the Women's Health Study. Perhaps this has to do with dosage? But Who Knows....It's an association study!!!
- Smoking Cuts Risk of Parkinson's Disease So that is what the media says about this study. Ok so now you have got me flipping out. No mechanism, No pathogenesis, No explanation.... Smoking kills, but at least it reduces your likelihood of ALSO having Parkinson's. Almost a 40% reduction in the likelihood of having Parkinson's. How? Who Cares....It's an association study! This kills me. The people could have predisposition genes for nicotine addiction/taste/etc which also have some salutatory effects. I do not think that smoking is what saves these patients brain cells!!!! But that's not what the press will tell you.
The Sherpa Says: What is sold as a good piece of science is quite often a piece of something else! Just because it was toiled over and hard work to develop it was done does not make it true, correct or even appropriate. I am here to say.....If it sounds fishy it probably smells fishy too. Throw out association studies until you have a reason for the association!!!
Posted by
Steve Murphy MD
at
3:58 PM
2
comments
Labels: brain cancer, Breast cancer, Colon cancer, gene sherpa, hormone therapy, parkinsons disease, quitting smoking, smoking, smoking cessation, The Gene Sherpa
Monday, June 25, 2007
2 months 3000 visitors!!!!!!
Thank you to everyone who picked up my slack on Sunday. I was unable to post the Medicine 2.0 Carnival because of an illness in the family :(
I would like to tell you how excited I am that I have reached 3000 sets of eyes. I am so invigorated by this whole process of blogging. I love educating the public and physicians and this blog is a labor of love. so thank you to all the readers out there.
Lastly I would like to draw attention to an amazing film director and radio talk show host Kathleen Slattery-Moschkau . She has just produced a new documentary to the medical community called PERx…it is available for viewing via the site www.perxinfo.org The film features internationally renowned experts from Harvard and other orgs. In a short time, continuing education credits will also be available to viewers and the film is also available to the general public. All for free (in order to watch the film, click on “educational modules”)
It is an amazing documentary. She has done others including Side Effects the movie with Grey's Anatomy start Katherine Heigl
Please take the time to watch this documentary as well as Side effects. You will be amazed at what you see.
Take Care
-The Sherpa
Posted by
Steve Murphy MD
at
12:40 PM
3
comments
Labels: gene sherpa, Katherine Heigl, Kathleen Slattery-Moschkau, personalized medicine, PERx, The Gene Sherpa
Friday, June 22, 2007
Harvard Honoring the Sherpa!

Today I was asked to be on the faculty of Harvard's famous Continuing Medical Education conference in the Genetic Basis of Adult Disease. I am extremely honored to be a part of this distinguished faculty. This year's conference will be held October 12-14th. The last conference topics and website are still up and I am certain the new one will be shortly. I highly recommend it for all physicians looking to become Sherpas or at least to stay up with the breakneck pace of genetic discovery in medicine. Several topics include:
- Genetic Causes of Heart Failure
- Genetics of Lipid Disorders
- Genetics of Cardiovascular Disease
- Genetics of Common Psychiatric Diagnoses
- Genetics, Lung Cancer and Treatment Responses
- Genetics of Gastro-Intestinal Diseases
- Barriers to the collection and use of the Family Health History in Primary Care
So who should attend this great conference?
Internal Medicine Docs
Family Physicians
Genetic Counselors
Registered Nurses
Nurse Practitioners
Physician Assistants
I was at the conference last year and am excited to be behind the podium this year. Please mark your calendars!!!!
Posted by
Steve Murphy MD
at
6:02 PM
1 comments
Labels: CME, Colon cancer, drudge report, francis collins, Harvard, internal medicine, Lung cancer, personalized medicine, scienceroll
Thursday, June 21, 2007
Forbes and Genetics Season 5
Posted by
Steve Murphy MD
at
11:20 AM
0
comments
Labels: amplichip, FTO, gene patents, gene tests, genetic counselor, IL23, psychiatry, quitting smoking, smoking



